Many patients with technically unresectable or medically inoperable hepatocellular carcinoma (HCC) had hepatic anatomy variations as a result of interfraction deformation during fractionated radiotherapy. We conducted this retrospective study to investigate interfractional normal liver dosimetric consequences via reconstructing weekly dose in HCC patients. Twenty-three patients with HCC received conventional fractionated three-dimensional conformal radiation therapy (3DCRT) were enrolled in this retrospective investigation. Among them, seven patients had been diagnosed of radiation-induced liver disease (RILD) and the other 16 patients had good prognosis after treatment course. The cone-beam CT (CBCT) scans were acquired once weekly for each patient throughout the treatment, deformable image registration (DIR) of planning CT (pCT) and CBCT was performed to acquire modified CBCT (mCBCT), and the structural contours were propagated by the DIR. The same plan was applied to mCBCT to perform dose calculation. Weekly dose distribution was displayed on the pCT dose space and compared using dose difference, target coverage, and dose volume histograms. Statistical analysis was performed to identify the significant dosimetric variations. Among the 23 patients, the three weekly normal liver D 50 increased by 0.2 Gy, 4.2 Gy, and 4.7 Gy, respectively, for patients with RILD, and 1.0 Gy, 2.7 Gy, and 3.1 Gy, respectively, for patients without RILD. Mean dose to the normal liver (D mean ) increased by 0.5 Gy, 2.6 Gy, and 4.0 Gy, respectively, for patients with RILD, and 0.4 Gy, 3.1 Gy, and 3.4 Gy, respectively, for patients without RILD. Regarding patients with RILD, the average values of the third weekly D 50 and D mean were both over hepatic radiation tolerance, while the values of patients without RILD were below. The dosimetric consequence showed that the liver dose between patients with and without RILD were different relative to the planned dose, and the RILD patients suffered from liver dose over hepatic radiation tolerance. Evaluation of routinely acquired CBCT images during radiation therapy provides biological information on the organs at risk, and dose estimation based on mCBCT could potentially form the basis for personalized response adaptive therapy. 
| INTRODUCTION
Radiotherapy has been an important treatment modality for patients who had an unresectable or inoperable terminal-stage hepatocellular carcinoma (HCC). 1 Meanwhile, image-guided radiotherapy (IGRT) incorporated with the technique of respiratory-control (e.g., Realtime Position Management ™ System, Varian Medical Systems, Palo
Alto, CA, USA) and highly conformal radiotherapy has better locoregional control rate and survival rate for HCC. 2 However, radiation-induced liver disease (RILD) is one of the most severe radiation-related complications for patients who undergo hepatic RT, which prevents radiation dose escalation and re-irradiation for hepatobiliary malignancies. 3 RILD typically occurs 4-8 weeks after RT completion, its clinical characteristics are manifested grossly as nonmalignant ascites, upper gastrointestinal hemorrhage, and veno-occlusive, which resemble Budd-Chiari syndrome, and RILD is almost fatal since there is no effective treatment at present. 4 Liang et al. conducted a retrospective study and reported that 19 of 128 (15%) patients were observed developed RILD over 4 weeks after hypo-fractionated three-dimensional conformal radiation therapy (3DCRT), while 85% of these RILD patients died from RILD despite receiving appropriate treatments. 5 Xu et al. reported that 17 of 109 patients developed RILD with elevations of AKP, or sGOT, and sGPT appearing in all patients within 4 months after irradiation, and noted that 13 of 17 (76%) died after onset of RILD. 6 Hence, a high mortality rate of RILD deserves special attention.
Liver is believed to be a typical parallel organ; the normal liver will escape from damage provided that an adequate normal liver volume is not irradiated to high doses. 7 Liang et al. proposed D mean for prediction of RILD, considering that liver received inhomogeneous dose and hepatic radiation tolerance had severe volume effect. 8 In their study, D mean of 23 Gy was estimated as the hepatic radiation tolerance for primary liver cancer patients with Child-Pugh Grade A cirrosis treated with 3DCRT, which produced a high prediction rate (72%). Prevention of RILD by keeping dose to normal liver below the hepatic radiation tolerance is of predominant importance when designing treatment plan, whereas the planned dose is generally assumed, inconsistent with actual delivered dose.
Radiotherapy evolves toward more adaptive techniques. According to the routine adaptive radiotherapy (ART) strategy, 9,10 a repeat imaging scan to check whether it needs a re-planning is implemented 2.5-3 weeks after the beginning of the treatment, whereas the time interval between the planning CT (pCT) and the repeat CT is too long to timely prevent the radiation overdose to the normal liver. 21 For the stomach and duodenum, the maximum dose was limited to 45 Gy, and the volume receiving > 22.5 Gy was limited to < 5 cm 3 ( Table 2) . 22 It was also required that prescription dose cover at least 95% of the PTV and 100% of the GTV when D mean was kept below 28 Gy. RT for HCC was deliv- 
2.B.2 | CBCT imaging

2.C.2 | Reconstruction of weekly dose
The method we proposed to reconstruct weekly dose while accounting for anatomic changes required the weekly CBCT and initial pCT, and the workflow consists of the following steps being illustrated in Fig. 1 .
The liver motion following respiration and the gantry rotation made the CBCT images more prone to blur, and the deteriorated image quality hampered reliability of CBCT-based dose has a stable and reliable HU-electron density relationship. The electronic density information was mapped from pCT to CBCT via DIR, and this process was repeated for each weekly CBCT available for the patient.
As seen from ( 
2.C.3 | Propagation of structural contours
Due to the complex and highly deformable nature of organ and target motion, a simple rigid registration, guided by bone matching, is insufficient. To account for the interfraction anatomic changes, starting with rigid registration to align these two sets of images, the DIR was executed on every case. And the accuracy of the propagated contours was checked by the attending radiation oncologist.
2.D | Dose assessment
The dose assessment was extended to examine the dosimetric impact within different structures, and DVH is a useful tool to assess 
2.E | Statistical analysis
Statistical analyses were implemented using SPSS software (SPSS ver.19.0, Inc., Chicago, IL, USA). The independent-samples t-test was performed to identify the significant dosimetric changes.
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F I G . 3. Checkerboard comparison between the pCT and mCBCT weekn image before deformable registration, and the arrows indicate the visible differences.; (a), (b), and (c), the pCT vs mCBCT week1 , (d), (e), and (f), pCT vs mCBCT week2 , and (g), (h), and (i), pCT vs mCBCT week3 .
F I G . 4. Example of slice and three-dimension region for a sample segmented using deformable registration propagated methods for mCBCTweek1, mCBCTweek2, and mCBCTweek3. The subset of slices was arbitrarily selected by increasing the slice numbers to approximately cover the entire liver volume. Figure 3 shows the checkerboard of pCT and weekly mCBCT, and we highlighted areas of misalignment in the checkerboard images before GFFD registration with arrows. In particular, it notices that the misalignment always occurs in liver and lung areas, where larger motion and deformation exists. In addition, the shape and position of the liver of the patient varies on different treatment fraction, and mCBCT week3 shows the most distinct visible difference among these three set of weekly mCBCT.
| RESULTS
3.A | Uncertainties of the anatomic variations
GFFD registration mapped the contours on CBCT from pCT to correct for the anatomic changes, and (Fig. 4) shows the interfractional liver shape results for a HCC patient. The subset of slices was arbitrarily selected by increasing the slice numbers to approximately cover the entire liver volume, and each column displayed the corresponding slice of the same patient.
3.B | Comparison of dosimetric parameters
Weekly dose was extended to the entire fraction and compared with the planned dose, and an example of patient without RILD was shown in Fig. 5 . The clinically significantly differences were observed in the high-dose region for the GTV, the week2 and week3 DVH curves illustrated that the prescribed dose was unable to cover the entire GTV, and the normal liver suffered increased dose.
As shown in Fig. 6 30 , and V 40 were computed and given in the top left of the plot, and the trend is measured here using the slope value. Figure 7 shows examples of absolute dose deviations displayed on the pCT space. Fig. 7(a) shows a non-RILD case while Fig. 7(b) shows a RILD case, and the range of dose deviation was expanded week by week in both cases, and the degree of dose deviation of RILD patient was observed higher than non-RILD patient. 
3.C | Dosimetric parameters correlated with RILD
Example of absolute dose deviation on pCT for patients without (a) and with (b) RILD. The dose deviation between pCT and mCBCT was shown in three different periods (top for week1, middle for week2 and bottom for week3), and a fractional reconstructed dose deviation from the planned dose (D mcbct -D plan ) are shown in the transverse (a1, b1, and c1), coronal (a2, b2, and c2), and sagittal (a3, b3, and c3) views, respectively. Each mCBCT was deformed to the pCT for dose subtraction.
without RILD. Neither the V 20 and V 40 contributed to the risk of developing RILD (Table 3 ).
The reconstructed weekly dose between patients with RILD and without RILD were compared in Table 4 showed significant difference in week3, respectively.
| DISCUSSION
Radiotherapy is commonly used to treat HCC at present, whereas RILD is a recognized life-threatening complication, occurred more frequently as the dose to liver increased. With the advent of highly conformal radiation treatment planning and delivery technology, tumoricidal doses could be delivered safely provided that the mean dose to the normal liver was limited to below hepatic irradiation tolerance. 26 In this study, that 7 of 23 (30.4%) patients had been diagnosis of RILD after RT does not represent the clinical incidence rate of RILD.
In addition, pioneering investigators has demonstrated that the severity of hepatic cirrhosis is the most significant independent clinical predictor for RILD, and more RILD cases are expected to occur in patients with Child-Pugh Grade B or C hepatic cirrhosis; 27 the acknowledged rationale is that the severely cirrhotic hepar is less tolerable to the irradiation of X-ray due to fact that cirrhosis hinders the repair of radiation injury along with the hepatocyte proliferation. 28 Thus, the baseline hepatic function status is an important factor for the occurrence of RILD as a limited number of researchers The clinical outcomes of a small-margin approach with frequent replanning strategy are unclear. Recent work on the dosimetric consequences of PTV margin size confirms that as the PTV margin decreases, accumulated OAR doses decrease, at the expense of an increased risk of target underdosing. 29 The re-planning strategy outlined in this study mitigated this risk of target miss and preserved the OAR dose sparing gains of small-margin IMRT for the population as a whole.
Note that the dose objectives of target and OARs may not be simultaneously met, and the loco-regional tumor control should be emphasized at the expense of OAR dose sparing. The anatomical change resulted in liver dose increase relative to planned dose week by week (Fig. 7) , and the dose difference was increased week by week (Fig. 8) . Although the planned dosimetric parameters were below the hepatic radiation tolerance, the planned one determined the baseline of the liver dose without considering the interfraction dose change. In this case, those patients who were diagnosed with RILD after RT were at the higher risk of liver overdose. Furthermore, Table 4 showed that the normal liver dosimetric value had a significant increasing trend from week1 to week2, and the liver overdose This study is not without limitations and assumptions. The primary limitation is that the weekly CBCT scans were extrapolated to 24-27 fractions, which depended on the fractionation scheme, and each scan was assumed to represent the patient anatomy until the next scan. We are currently in the process of recruiting patients to have CBCT scans performed three times weekly to validate this study. This study also assumed perfect bone to bone matching to achieve zero setup errors. Furthermore, due to the respiratory and liver motion during CBCT scan, the CBCT indicates an intricate effect of multiple respiratory phase. 30 Moreover, the often significant intra-fraction motion 31 was assumed to be zero in this study.
This may have further underestimated the dosimetric consequences of random anatomical variations.
| CONCLUSION S
In this work, we proposed to deform the planning CT to CBCT for generating a reconstructed dosimetry to avoid the inaccuracies related to the inherent CBCT artifacts. Through the weekly reconstructed liver dose, patients with RILD were found over hepatic radiation tolerance before re-planning, and patients without RILD were found below the tolerance. The modified CBCT may be a useful 
CONFLICTS OF INTEREST
The authors have no relevant conflicts of interest to disclose.
